Insight Report: Potential Therapeutic Targets for Alzheimer’s | BioSpace

What is the best way to prevent or even reverse Alzheimer’s disease?

The plot just thickened when and recently announced they will pursue FDA approval for aducanumab, the anti-amyloid antibody drug they previously predicted would not hit its primary endpoints in the global Phase 3 trials ENGAGE and EMERGE and the Phase 2 trial EVOLVE

Keep the story going. Sign up for an extra free read.

Chelsea Weidman Burke, M.S.

Written by

Biochemist, lab tech & freelance science writer (genetics, immunotherapy, cancer, Alzheimer’s). Follow my publication! https://medium.com/chemically-inquisitive

The Startup

Medium's largest active publication, followed by +542K people. Follow to join our community.

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch
Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore
Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade